Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In proof-of-concept studies, NNMT inhibitors (NNMTis) have demonstrated promise as potential treatments for obesity and obesity-related metabolic comorbidities (e.g., T2D, fatty liver) 8,9,13
115.6 [SD 6.2] mmol/L, p = 0.52)
Periodic transaminases measurements should be made during prolonged treatment with diclofenac because severe hepatotoxicity may develop without a prodrome of distinguishing symptoms
Sterile, lyophilized peptide for research applications
US$ 23.51
US$ 28.82
US$ 20.55
US$ 24.11
US$ 21.52
US$ 21.10
US$ 24.26
US$ 23.20
